A Study of BRII-297 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

May 15, 2023

Primary Completion Date

November 21, 2023

Study Completion Date

January 17, 2024

Conditions
Postpartum Depression
Interventions
DRUG

BRII-297

Escalating doses of BRII-297 will be given in different cohorts i.e., Cohorts 1 through 6

DRUG

Placebo

Escalating doses of placebo will be given in different cohorts i.e., Cohorts 1 through 6

Trial Locations (1)

5000

CMAX, Adelaide

Sponsors
All Listed Sponsors
lead

Brii Biosciences Limited

INDUSTRY

NCT05845840 - A Study of BRII-297 in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter